Assessment of Racial Disparities in Biomarkers for Alzheimer Disease-Reference-Cited by-同舟云学术

Assessment of Racial Disparities in Biomarkers for Alzheimer Disease

Published:2019-03-01 Issue:3 Volume:76 Page:264
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Morris John C.¹²,Schindler Suzanne E.¹²,McCue Lena M.²³,Moulder Krista L.¹²,Benzinger Tammie L. S.²⁴,Cruchaga Carlos²⁵,Fagan Anne M.¹²,Grant Elizabeth²³,Gordon Brian A.²⁴,Holtzman David M.¹²,Xiong Chengjie²³

Affiliation:

1. Department of Neurology, Washington University School of Medicine, St Louis, Missouri

2. Knight Alzheimer Disease Research Center, Washington University School of Medicine, St Louis, Missouri

3. Division of Biostatistics, Washington University School of Medicine, St Louis, Missouri

4. Department of Radiology, Washington University School of Medicine, St Louis, Missouri

5. Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri

Publisher

American Medical Association (AMA)

Subject

Neurology (clinical)

Link

http:///jamaneurology/article-pdf/76/3/264/17356218/jamaneurology_morris_2019_oi_180096.pdf

Reference50 articles.

1. Severe dementia: prevalence and clinical features in a biracial US population.;Schoenberg;Arch Neurol,1985

2. Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan.;Tang;Neurology,2001

3. Risk of dementia among white and African American relatives of patients with Alzheimer disease.;Green;JAMA,2002

4. Inequalities in dementia incidence between six racial and ethnic groups over 14 years.;Mayeda;Alzheimers Dement,2016

5. The prevalence and 3-year incidence of dementia in older black and white community residents.;Fillenbaum;J Clin Epidemiol,1998

Cited by 254 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: an update of the literature;Expert Review of Neurotherapeutics;2024-09-04

2. 18F-FDG-PET-based deep learning for predicting cognitive decline in non-demented elderly across the Alzheimer’s disease clinical spectrum;Radiology Advances;2024-08-10

3. Nomination of a novel plasma protein biomarker panel capable of classifying Alzheimer’s disease dementia with high accuracy in an African American cohort;2024-07-29

4. Involvement of the choroid plexus in Alzheimer’s disease pathophysiology: findings from mouse and human proteomic studies;Fluids and Barriers of the CNS;2024-07-18

5. Correlations between plasma markers and brain Aβ deposition across the AD continuum: Evidence from SILCODE;Alzheimer's & Dementia;2024-07-10